|
1
|
World Health Organization (WHO): Factsheet
of Preterm Birth. WHO, Geneva, 2018. https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
|
|
2
|
Pan American Health Organization (PAHO):
152 million babies born preterm in the last decade. PAHO,
Washington, DC, 2013. https://www.paho.org/en/news/15-6-2023-152-million-babies-born-preterm-last-decade#:~:text=An%20estimated%2013.4%20million%20babies,37%20weeks%20of%20pregnancy)%20worldwide.
Accessed Sep 28, 2023.
|
|
3
|
Cao G, Liu J and Liu M: Global, regional,
and national incidence and mortality of neonatal preterm birth,
1990-2019. JAMA Pediatr. 176(787)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bolisetty S, Dhawan A, Abdel-Latif M,
Bajuk B, Stack J and Oei JL: New South Wales and Australian Capital
Territory Neonatal Intensive Care Units' Data Collection.
Intraventricular hemorrhage and neurodevelopmental outcomes in
extreme preterm infants. Pediatrics. 133:55–62. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Beam AL, Fried I, Palmer N, Agniel D, Brat
G, Fox K, Kohane I, Sinaiko A, Zupancic JAF and Armstrong J:
Estimates of healthcare spending for preterm and low-birthweight
infants in a commercially insured population: 2008-2016. J
Perinatol. 40:1091–1099. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Romero R, Dey SK and Fisher SJ: Preterm
labor: One syndrome, many causes. Science. 345:760–765.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bastek JA, Gómez LM and Elovitz MA: The
role of inflammation and infection in preterm birth. Clin
Perinatol. 38:385–406. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bariani MV, Correa F, Leishman E,
Domínguez Rubio AP, Arias A, Stern A, Bradshaw HB and Franchi AM:
Resveratrol protects from lipopolysaccharide-induced inflammation
in the uterus and prevents experimental preterm birth. Mol Hum
Reprod. 23:571–581. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tency I: Inflammatory response in maternal
serum during preterm labour. Facts Views Vis Obgyn. 6:19–30.
2014.PubMed/NCBI
|
|
10
|
Elovitz MA, Wang Z, Chien EK, Rychlik DF
and Phillippe M: A new model for Inflammation-Induced preterm
birth. Am J Pathol. 163:2103–2111. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Deng W, Cha J, Yuan J, Haraguchi H, Bartos
A, Leishman E, Viollet B, Bradshaw HB, Hirota Y and Dey SK: p53
coordinates decidual sestrin 2/AMPK/mTORC1 signaling to govern
parturition timing. J Clin Invest. 126:2941–2954. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Simhan HN and Caritis SN: Prevention of
preterm delivery. N Engl J Med. 357:477–487. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Abramovici A, Cantu J and Jenkins SM:
Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin
North Am. 39:77–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alfirevic Z: Tocolytics: Do they actually
work? BMJ. 345:e6531. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Croen LA, Connors SL, Matevia M, Qian Y,
Newschaffer C and Zimmerman AW: Prenatal exposure to β2-adrenergic
receptor agonists and risk of autism spectrum disorders. J Neurodev
Disord. 3:307–315. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gidaya NB, Lee BK, Burstyn I, Michael Y,
Newschaffer CJ and Mortensen EL: In utero exposure to
β-2-Adrenergic receptor agonist drugs and risk for autism spectrum
disorders. Pediatrics. 137(e20151316)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Furuya H, Taguchi A, Kawana K, Yamashita
A, Inoue E, Yoshida M, Nakamura H, Fujimoto A, Inoue T, Sato M, et
al: Resveratrol protects against pathological preterm birth by
suppression of Macrophage-Mediated Inflammation. Reprod Cie.
22:1561–1568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bourque SL, Dolinsky VW, Dyck JRB and
Davidge ST: Maternal resveratrol treatment during pregnancy
improves adverse fetal outcomes in a rat model of severe hypoxia.
Placenta. 33:449–452. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Poudel R, Stanley JL, Rueda-Clausen CF,
Andersson IJ, Sibley CP, Davidge ST and Baker PN: Effects of
resveratrol in pregnancy using murine models with reduced blood
supply to the uterus. PLoS One. 8(e64401)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Schneider K, Schwarz M, Burkholder I,
Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, Hartung T and
Hoffmann S: ‘ToxRTool’, a new tool to assess the reliability of
toxicological data. Toxicol Lett. 189:138–144. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Valenti C, Billi M, Pancrazi GL, Calabria
E, Armogida NG, Tortora G, Pagano S, Barnaba P and Marinucci L:
Biological effects of cannabidiol on human cancer cells: Systematic
review of the literature. Pharmacol Res. 181(106267)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Moser VC, Morris-Schaffer K, Richardson JR
and Li AA: Glyphosate and neurological outcomes: A systematic
literature review of animal studies. J Toxicol Environ Health B
Crit Rev. 25:162–209. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gupta M, Singh D, Rastogi S, Siddique HR,
Al-Dayan N, Ahmad A, Sikander M and Sarwat M: Anti-cancer activity
of guggulsterone by modulating apoptotic markers: A systematic
review and meta-analysis. Front Pharmacol.
14(1155163)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
EU Science Hub: ToxRTool-Toxicological
data reliability assessment tool. In: European Commission for
Scientific Tools and Databases. European Commission, 2023.
https://joint-research-centre.ec.europa.eu/scientific-tools-and-databases/toxrtool-toxicological-data-reliability-assessment-tool_en.
Accessed Sep 21, 2023.
|
|
26
|
University of Pittsburgh: Health Research
Reporting Guidelines, Study Execution Manuals, Critical Appraisal,
Risk of Bias, and Non-reporting Biases: From Cochrane Handbook for
Systematic Reviews of Interventions [Internet]. University of
Pittsburgh: Health Sciences Library System Guides, 2023. https://hsls.libguides.com/reporting-study-tools/risk-of-bias.
Accessed Sep 21, 2023.
|
|
27
|
Osmanovic A, Halilovic S, Kurtovic-Kozaric
A and Hadziabdic N: Evaluation of periodontal ligament cell
viability in different storage media based on human PDL cell
culture experiments-A systematic review. Dental Traumatol.
34:384–393. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
National Toxicology Program: Handbook for
conducting a literature-based health assessment using OHAT approach
for systemic review and evidence integration. National Institute of
Environmental Health Science, pp1-102, 2019.
|
|
29
|
Puidokas T, Kubilius M, Stumbras A and
Juodzbalys G: Effect of leukocytes included in platelet
concentrates on cell behaviour. Platelets. 30:937–945.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Center for Evidence-Based Medicine (CEBM):
OCEMB Levels of Evidence. CEBM, Oxford, 2011. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.
Accessed Sep 21, 2023.
|
|
31
|
Novaković R, Radunović N,
Marković-Lipkovski J, Ćirović S, Beleslin-Čokić B, Ilić B, Ivković
B, Heinle H, Živanović V and Gojković-Bukarica LJ: Effects of the
polyphenol resveratrol on contractility of human term pregnant
myometrium. Mol Hum Reprod. 21:545–551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wilson A, Hodgetts-Morton VA, Marson EJ,
Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A,
Chou D, Oladapo OT, et al: Tocolytics for delaying preterm birth: A
network meta-analysis. Cochrane Database Syst Rev.
8(CD014978)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Abd El-Mohsen M, Bayele H, Kuhnle G,
Gibson G, Debnam E, Kaila Srai S, Rice-Evans C and Spencer JP:
Distribution of [3H]trans-resveratrol in rat tissues following oral
administration. Br J Nutr. 96:62–70. 2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Walle T, Hsieh F, DeLegge MH, Oatis JE and
Walle UK: High absorption but very low bioavailability of oral
resveratrol in humans. Drug Metab Dispos. 32:1377–1382.
2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Walle T: Bioavailability of resveratrol.
Ann N Y Acad Sci. 1215:9–15. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
la Porte C, Voduc N, Zhang G, Seguin I,
Tardiff D, Singhal N and Cameron DW: Steady-State pharmacokinetics
and tolerability of Trans-Resveratrol 2000 mg twice daily with
food, quercetin and alcohol (Ethanol) in healthy human subjects.
Clin Pharmacokinet. 49:449–454. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Brown VA, Patel KR, Viskaduraki M, Crowell
JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli
G, et al: Repeat dose study of the cancer chemopreventive agent
resveratrol in healthy volunteers: Safety, pharmacokinetics, and
effect on the Insulin-like growth factor axis. Cancer Res.
70:9003–9011. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gracie S, Pennell C, Ekman-Ordeberg G, Lye
S, McManaman J, Williams S, Palmer L, Kelley M, Menon R and Gravett
M: PREBIC ‘-Omics’ Research Group. An integrated systems biology
approach to the study of preterm birth using ‘-omic’ technology-a
guideline for research. BMC Pregnancy Childbirth.
11(71)2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Green ES and Arck PC: Pathogenesis of
preterm birth: Bidirectional inflammation in mother and fetus.
Semin Immunopathol. 42:413–429. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
McCarthy R, Martin-Fairey C, Sojka DK,
Herzog ED, Jungheim ES, Stout MJ, Fay JC, Mahendroo M, Reese J,
Herington JL, et al: Mouse models of preterm birth: Suggested
assessment and reporting guidelines. Biol Reprod. 99:922–937.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Romero R and Tartakovsky B: The natural
interleukin-1 receptor antagonist prevents interleukin-l-induced
preterm delivery in mice. Am J Obstet Gynecol. 167:1041–1045.
1992.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Robertson SA, Christiaens I, Dorian CL,
Zaragoza DB, Care AS, Banks AM and Olson DM: Interleukin-6 is an
essential determinant of on-time parturition in the mouse.
Endocrinology. 151:3996–4006. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Montalbano AP, Hawgood S and Mendelson CR:
Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2
manifest delayed parturition and decreased expression of
inflammatory and contractile genes. Endocrinology. 154:483–498.
2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gonzalez JM, Franzke CW, Yang F, Romero R
and Girardi G: Complement activation triggers metalloproteinases
release inducing cervical remodeling and preterm birth in mice. Am
J Pathol. 179:838–849. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wahid HH, Dorian CL, Chin PY, Hutchinson
MR, Rice KC, Olson DM, Moldenhauer LM and Robertson SA: Toll-Like
Receptor 4 Is an essential upstream regulator of On-Time
parturition and perinatal viability in mice. Endocrinology.
156:3828–3841. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Krediet TG, Wiertsema SP, Vossers MJ,
Hoeks SBEA, Fleer A, Ruven HJ and Rijkers GT: Toll-like receptor 2
polymorphism is associated with preterm birth. Pediatr Res.
62:474–476. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bayar E, Bennett PR, Chan D, Sykes L and
MacIntyre DA: The pregnancy microbiome and preterm birth. Semin
Immunopathol. 42:487–499. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Andrews WW, Goldenberg RL, Hauth JC,
Cliver SP, Copper R and Conner M: Interconceptional antibiotics to
prevent spontaneous preterm birth: A randomized clinical trial. Am
J Obstet Gynecol. 194:617–623. 2006.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Abedini E, Khodadadi E, Zeinalzadeh E,
Moaddab SR, Asgharzadeh M, Mehramouz B, Dao S and Samadi Kafil H: A
comprehensive study on the antimicrobial properties of resveratrol
as an alternative therapy. Evid Based Complement Alternat Med.
2021(8866311)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ma DSL, Tan LTH, Chan KG, Yap WH,
Pusparajah P, Chuah LH, Ming LC, Khan TM, Lee LH and Goh BH:
Resveratrol-Potential antibacterial agent against foodborne
pathogens. Front Pharmacol. 9(102)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Roberts RA, Laskin DL, Smith CV, Robertson
FM, Allen EMG, Doorn JA and Slikker W: Nitrative and oxidative
stress in toxicology and disease. Toxicol Sci. 112:4–16.
2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Meng T, Xiao D, Muhammed A, Deng J, Chen L
and He J: Anti-Inflammatory action and mechanisms of resveratrol.
Molecules. 26(229)2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Gómez-Chávez F, Correa D,
Navarrete-Meneses P, Cancino-Diaz JC, Cancino-Diaz ME and
Rodríguez-Martínez S: NF-κB and its regulators during pregnancy.
Front Immunol. 12(679106)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Malaguarnera. Influence of resveratrol on
the immune response. Nutrients. 11(946)2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther.
2(17023)2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Klawitter M, Hakozaki M, Kobayashi H,
Krupkova O, Quero L, Ospelt C, Gay S, Hausmann O, Liebscher T,
Meier U, et al: Expression and regulation of toll-like receptors
(TLRs) in human intervertebral disc cells. Eur Spine J.
23:1878–1891. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lappas M, Mitton A, Lim R, Barker G, Riley
C and Permezel M: SIRT1 Is a novel regulator of key pathways of
human labor1. Biol Reprod. 84:167–178. 2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Manna SK, Mukhopadhyay A and Aggarwal BB:
Resveratrol suppresses TNF-induced activation of nuclear
transcription factors NF-kappa B, activator protein-1, and
apoptosis: Potential role of reactive oxygen intermediates and
lipid peroxidation. J Immunol. 164:6509–6519. 2000.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu
X, Zou H and Qiu J: Activation of sirt1 by resveratrol inhibits
TNF-α induced inflammation in fibroblasts. PLoS One.
6(e27081)2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Taguchi A, Yamashita A, Kawana K,
Nagamatsu T, Furuya H, Inoue E, Osuga Y and Fujii T: Recent
progress in therapeutics for inflammation-associated preterm birth:
A review. Reprod Sci. 24:7–18. 2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Taguchi A, Wada-Hiraike O, Kawana K, Koga
K, Yamashita A, Shirane A, Urata Y, Kozuma S, Osuga Y and Fujii T:
Resveratrol suppresses inflammatory responses in endometrial
stromal cells derived from endometriosis: A possible role of the
sirtuin 1 pathway. J Obstet Gynaecol Res. 40:770–778.
2014.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Vidal MS, Lintao RCV, Severino MEL,
Tantengco OAG and Menon R: Spontaneous preterm birth: Involvement
of multiple feto-maternal tissues and organ systems, differing
mechanisms, and pathways. Front Endocrinol (Lausanne).
13(1015622)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Wood EM, Hornaday KK and Slater DM:
Prostaglandins in biofluids in pregnancy and labour: A systematic
review. PLoS One. 16(e0260115)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Yamashita A, Kawana K, Tomio K, Taguchi A,
Isobe Y, Iwamoto R, Masuda K, Furuya H, Nagamatsu T, Nagasaka K, et
al: Increased tissue levels of omega-3 polyunsaturated fatty acids
prevents pathological preterm birth. Sci Rep.
3(3113)2013.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Li WJ, Lu JW, Zhang CY, Wang WS, Ying H,
Myatt L and Sun K: PGE2 vs PGF2α in human parturition. Placenta.
104:208–219. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Alfirevic Z, Keeney E, Dowswell T, Welton
NJ, Dias S, Jones LV, Navaratnam K and Caldwell DM: Labour
induction with prostaglandins: A systematic re view and network
meta-analysis. BMJ. 350(h217)2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Sykes L, MacIntyre DA, Teoh TG and Bennett
PR: Anti-inflammatory prostaglandins for the prevention of preterm
labour. Reproduction. 148:R29–R40. 2014.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Challis JR, Lockwood CJ, Myatt L, Norman
JE, Strauss JF and Petraglia F: Inflammation and Pregnancy. Reprod
Sci. 16:206–215. 2009.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhang Y, Desai A, Yang SY, Bae KB, Antczak
MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, et al:
Inhibition of the prostaglandin-degrading enzyme 15-PGDH
potentiates tissue regeneration. Science.
348(aaa2340)2015.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Mitchell MD, Rice GE, Vaswani K, Kvaskoff
D and Peiris HN: Differential regulation of eicosanoid and
endocannabinoid production by inflammatory mediators in human
choriodecidua. PLoS One. 11(e0148306)2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Maia J, Fonseca B, Teixeira N and
Correia-da-Silva G: The fundamental role of the endocannabinoid
system in endometrium and placenta: Implications in
pathophysiological aspects of uterine and pregnancy disorders. Hum
Reprod Update. 26:586–602. 2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Nallendran V, Lam PM, Marczylo TH, Bankart
MJ, Taylor AH, Taylor DJ and Konje JC: The plasma levels of the
endocannabinoid, anandamide, increase with the induction of labour.
BJOG. 117:863–869. 2010.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Bariani MV, Domínguez Rubio AP, Cella M,
Burdet J, Franchi AM and Aisemberg J: Role of the endocannabinoid
system in the mechanisms involved in the LPS-induced preterm labor.
Reproduction. 150:463–472. 2015.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Komarnytsky S, Rathinasabapathy T, Wagner
C, Metzger B, Carlisle C, Panda C, Le Brun-Blashka S, Troup JP and
Varadharaj S: Endocannabinoid system and its regulation by
polyunsaturated fatty acids and full spectrum hemp oils. Int J Mol
Sci. 22(5479)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Rava A and Trezza V: Emerging roles of
endocannabinoids as key lipid mediators for a successful pregnancy.
Int J Mol Sci. 24(5220)2023.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Dennedy MC, Friel AM, Houlihan DD,
Broderick VM, Smith T and Morrison JJ: Cannabinoids and the human
uterus during pregnancy. Am J Obstet Gynecol. 190:2–9.
2004.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Mitchell MD, Sato TA, Wang A, Keelan JA,
Ponnampalam AP and Glass M: Cannabinoids stimulate prostaglandin
production by human gestational tissues through a tissue- and
CB1-receptor-specific mechanism. Am J Physiol Endocrinol Metab.
294:E352–E356. 2008.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Kozakiewicz ML, Grotegut CA and Howlett
AC: Endocannabinoid system in pregnancy maintenance and labor: A
mini-review. Front Endocrinol (Lausanne). 12(699951)2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Booker L, Kinsey SG, Abdullah RA, Blankman
JL, Long JZ, Ezzili C, Boger DL, Cravatt BF and Lichtman AH: The
fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the
nervous system to reverse LPS-induced tactile allodynia in mice. Br
J Pharmacol. 165:2485–2496. 2012.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Sun X, Deng W, Li Y, Tang S, Leishman E,
Bradshaw HB and Dey SK: Sustained endocannabinoid signaling
compromises decidual function and promotes inflammation-induced
preterm birth. J Biol Chem. 291:8231–8240. 2016.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Donvito G, Nass SR, Wilkerson JL, Curry
ZA, Schurman LD, Kinsey SG and Lichtman AH: The endogenous
cannabinoid system: A budding source of targets for treating
inflammatory and neuropathic pain. Neuropsychopharmacology.
43:52–79. 2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Connor M, Vaughan CW and Vandenberg RJ:
N-Acyl amino acids and N-acyl neurotransmitter conjugates:
Neuromodulators and probes for new drug targets. Br J Pharmacol.
160:1857–1871. 2010.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Godlewski G, Offertáler L, Osei-Hyiaman D,
Mo FM, Harvey-White J, Liu J, Davis MI, Zhang L, Razdan RK, Milman
G, et al: The endogenous brain constituent N-Arachidonoyl l-Serine
Is an activator of large conductance Ca 2+-Activated K+ channels. J
Pharmacol Exp Ther. 328:351–361. 2009.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Guo J, Williams DJ and Ikeda SR:
N-Arachidonoyl L-Serine, a putative endocannabinoid, alters the
activation of N-Type Ca2+ Channels in sympathetic neurons. J
Neurophysiol. 100:1147–151. 2008.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Grazia Cascio M, Minassi A, Ligresti A,
Appendino G, Burstein S and Di Marzo V: A structure-activity
relationship study on N-arachidonoyl-amino acids as possible
endogenous inhibitors of fatty acid amide hydrolase. Biochem
Biophys Res Commun. 314:192–196. 2004.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Bachkangi P, Taylor AH, Bari M, Maccarrone
M and Konje JC: Prediction of preterm labour from a single blood
test: The role of the endocannabinoid system in predicting preterm
birth in high-risk women. Eur J Obstet Gynecol Reprod Biol.
243:1–6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Deutsch DG: A personal retrospective:
Elevating anandamide (AEA) by targeting fatty acid amide hydrolase
(FAAH) and the fatty acid binding proteins (FABPs). Front
Pharmacol. 7(370)2016.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Liu J, Bátkai S, Pacher P, Harvey-White J,
Wagner JA, Cravatt BF, Gao B and Kunos G: Lipopolysaccharide
induces anandamide synthesis in macrophages via
CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of
platelet-activating factor. J Biol Chem. 278:45034–45039.
2003.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Nagarkatti P, Pandey R, Rieder SA, Hegde
VL and Nagarkatti M: Cannabinoids as novel anti-inflammatory drugs.
Future Med Chem. 1:1333–1349. 2009.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Maccarrone M, Valensise H, Bari M,
Lazzarin N, Romanini C and Finazzi-Agrò A: Relation between
decreased anandamide hydrolase concentrations in human lymphocytes
and miscarriage. Lancet. 355:1326–1329. 2000.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Dong C, Chen J, Harrington A, Vinod KY,
Hegde ML and Hegde VL: Cannabinoid exposure during pregnancy and
its impact on immune function. Cell Mol Life Sci. 76:729–743.
2019.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Hirota Y, Cha J, Yoshie M, Daikoku T and
Dey SK: Heightened uterine mammalian target of rapamycin complex 1
(mTORC1) signaling provokes preterm birth in mice. Proc Natl Acad
Sci USA. 108:18073–18078. 2011.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Wolfson ML, Aisemberg J, Correa F and
Franchi AM: Peripheral blood mononuclear cells infiltration
downregulates decidual FAAH activity in an LPS-Induced embryo
resorption model. J Cell Physiol. 232:1441–1447. 2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Cox LS and Redman C: The role of cellular
senescence in ageing of the placenta. Placenta. 52:139–145.
2017.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Singh M, Parent S, Leblanc V and Asselin
E: Resveratrol modulates the expression of PTGS2 and cellular
proliferation in the normal rat endometrium in an AKT-Dependent
Manner1. Biol Reprod. 84:1045–1052. 2011.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Rajkovic J, Djokic V, Gostimirovic M,
Gojkovic-Bukarica L, Martorell M, Sharifi-Rad J and Novakovic R:
Potassium channels on smooth muscle as a molecular target for
plant-derived Resveratrol. Cell Mol Biol (Noisy-le-Grand).
66:133–144. 2020.PubMed/NCBI
|
|
97
|
Carreiro JN, Magnani M, Jobling P, van
Helden DF, Nalivaiko E and Braga VA: Resveratrol restores uterine
contractions during hypoxia by blockade of ATP-sensitive potassium
channels. J Funct Foods. 33:307–313. 2017.
|
|
98
|
Lim R, Barker G and Lappas M: Activation
of AMPK in human fetal membranes alleviates infection-induced
expression of pro-inflammatory and pro-labour mediators. Placenta.
36:454–462. 2015.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Novakovic R, Ilic B, Beleslin-Cokic B,
Radunovic N, Heinle H, Scepanovic R and Gojkovic-Bukarica L: The
effect of resveratrol on contractility of non-pregnant rat uterus:
The contribution of K(+) channels. J Physiol Pharmacol. 64:795–805.
2013.PubMed/NCBI
|
|
100
|
Okawa T, Longo M, Vedernikov YP, Chwalisz
K, Saade GR and Garfield RE: Role of nucleotide cyclases in the
inhibition of pregnant rat uterine contractions by the openers of
potassium channels. Am J Obstet Gynecol. 182:913–918.
2000.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Brainard AM, Korovkina VP and England SK:
Potassium channels and uterine function. Semin Cell Dev Biol.
18:332–339. 2007.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Zheng S, Feng Q, Cheng J and Zheng J:
Maternal resveratrol consumption and its programming effects on
metabolic health in offspring mechanisms and potential
implications. Biosci Rep. 38(BSR20171741)2018.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Azachi M, Yatuv R, Katz A, Hagay Y and
Danon A: A novel red grape cells complex: Health effects and
bioavailability of natural resveratrol. Int J Food Sci Nutr.
65:848–855. 2014.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Wang P and Sang S: Metabolism and
pharmacokinetics of resveratrol and pterostilbene. BioFactors.
44:16–25. 2018.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Pollack RM and Crandall JP: Resveratrol:
Therapeutic potential for improving cardiometabolic health. Am J
Hypertens. 26:1260–1268. 2013.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Shrikanta A, Kumar A and Govindaswamy V:
Resveratrol content and antioxidant properties of underutilized
fruits. J Food Sci Technol. 52:383–390. 2015.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Cione E, La Torre C, Cannataro R, Caroleo
MC, Plastina P and Gallelli L: Quercetin, Epigallocatechin gallate,
curcumin, and resveratrol: From dietary sources to human MicroRNA
modulation. Molecules. 25(63)2019.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Weiskirchen S and Weiskirchen R:
Resveratrol: How much wine do you have to drink to stay healthy?
Adv Nutr. 7:706–718. 2016.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Kuršvietienė L, Stanevičienė I,
Mongirdienė A and Bernatonienė J: Multiplicity of effects and
health benefits of resveratrol. Medicina (Kaunas). 52:148–155.
2016.PubMed/NCBI View Article : Google Scholar
|
